Bone Changes With Long-Acting Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention in Cisgender Men and Transgender Women: HPTN 083

By afschroeder • July 2, 2025

Brown TT, Arao RF, Warsi M, Phanuphak N, Vasconcelos R, Oyedele T, Sullivan PA, Hanscom B, Rooney JF, Rinehart AR, McCauley M, Grinsztejn B, Landovitz RJ. Bone Changes With Long-Acting Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention in Cisgender Men and Transgender Women: HPTN 083. Clin Infect Dis. 2025 Jul 1:ciaf221. doi: 10.1093/cid/ciaf221. Epub ahead of print. PMID: 40590452.

Tags: Bone mineral density, Cabotegravir, HIV Pre-Exposure Prophylaxis, Infectious Diseases, Publications, tenofovir disoproxil fumarate

Adhesin Als4112 promotes Candida auris skin colonization through interactions with keratinocytes and extracellular matrix proteins

Zhao G, Lyu J, Veniaminova NA, Zarnowski R, Mattos E, Johnson CJ, Quintanilla D, Hautau H, Hold LA, Xu B, Anku JAE, Dasgupta K, Hale[...]

A spatial transcriptomic atlas of the host response to oropharyngeal candidiasis

Nabeela S, McSwiggin H, Magalhaes RDM, Mattos EC, Mannan M, Dillon JT, Barbarino A, Youssef EG, Singh S, Yan W, Ibrahim AS, Conti HR, Uppuluri[...]

Strain background interacts with chromosome 7 aneuploidy to determine commensal and virulence phenotypes in Candida albicans

Mishra A, Solis NV, Dietz SM, Crouch AL, Filler SG, Anderson MZ. Strain background interacts with chromosome 7 aneuploidy to determine commensal and virulence phenotypes[...]